Development of a conceptual model of adherence to oral anticoagulants to reduce risk of stroke in patients with atrial fibrillation

Journal of Managed Care Pharmacy

Volumn 18, Issue 5, 2012, Pages 351-362

  Brown, T Michelle ^a   Siu, Kimberly ^b   Walker, David ^b   Pladevall Vila, Manel ^a   Sander, Stephen ^b   Mordin, Margaret ^a  

^a RTI HEALTH SOLUTIONS   (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CHOLESTEROL; CLOPIDOGREL; DIPYRIDAMOLE; WARFARIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONCEPTUAL FRAMEWORK; DIABETES MELLITUS; FEEDBACK SYSTEM; FEMALE; HEALTH CARE PERSONNEL; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VALVE REPLACEMENT; HUMAN; HYPERTENSION; MALE; MEDICAL LITERATURE; PATIENT ATTITUDE; PATIENT COMPLIANCE; QUALITATIVE RESEARCH; RISK REDUCTION; STROKE;

EID: 84864831363     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2012.18.5.351     Document Type: Article

References (33)

1. Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009;104(11):1534-39.
2. Ryder KM, Benjamin EJ. Epidemiology and significance of atrial fibrillation. Am J Cardiol. 1999;84(9A):131R-138R.
3. Wattigney WA, Mensah GA, Croft JB. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation. 2003;108(6):711-16. Available at: http://circ.ahajournals.org/content/108/6/711.long. Accessed May 16, 2012.
4. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983-88. Available at: http://stroke.ahajournals.org/content/22/8/983.long. Accessed May 16, 2012.
5. Rose AJ, Ozonoff A, Grant RW, Henault LE, Hylek EM. Epidemiology of subtherapeutic anticoagulation in the United States. Circ Cardiovasc Qual Outcomes. 2009;2(6):591-97. Available at: http://circoutcomes.ahajournals.org/content/2/6/591.full.pdf+html. Accessed May 16, 2012.
6. Jones M, McEwan P, Morgan CL, Peters JR, Goodfellow J, Currie CJ. Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population. Heart. 2005;91(4):472-77. Available at: http://heart.bmj.com/content/91/4/472.full. Accessed May 16, 2012.
7. De Schryver EL, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A; Dutch TIA trial and SPIRIT study groups. Non-adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke. J Neurol. 2005;252(11):1316-21.
8. Gulløv AL, Koefoed BG, Petersen P. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation. Arch Intern Med. 1999;159(12):1322-28. Available at: http://archinte.ama-assn.org/cgi/content/full/159/12/1322. Accessed May 16, 2012.
9. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention. A population-based study. Ann Intern Med. 1999;130(1):14-22. Available at: http://www.annals.org/content/130/1/14.full.pdf. Accessed May 16, 2012.
10. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365(21):2002-12.
11. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-97.
12. Reynolds MR, Shah J, Essebag V, et al. Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry. Am J Cardiol. 2006;97(4):538-43.
13. Parker CS, Chen Z, Price M, et al. Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE study. J Gen Intern Med. 2007;22(9):1254-59. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219760/. Accessed May 16, 2012.
14. Cohen AT, Maillardet L, Yavin Y. Will a once-weekly anticoagulant for the treatment and secondary prevention of thromboembolism improve adherence? Thromb Haemost. 2009;101(3):422-27.
15. Wilson IB, Cleary PD. Linking clinical variables with healthrelated quality of life. A conceptual model of patient outcomes. JAMA. 1995;273(1):59-65.
16. Murray MD, Morrow DG, Weiner M, et al. A conceptual framework to study medication adherence in older adults. Am J Geriatr Pharmacother. 2004;2(1):36-43.
17. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370-75. Available at: http://jama.amaassn.org/content/285/18/2370.long. Accessed May 16, 2012.
18. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74.
19. Davis NJ, Billett HH, Cohen HW, Arnsten JH. Impact of adherence, knowledge, and quality of life on anticoagulation control. Ann Pharmacother. 2005;39(4):632-36.
20. Case Management Society of America (CMSA). CMAG: Case management adherence guidelines. Guidelines from the Case Management Society of America for improving patient adherence to medication therapies. Version 2.0. June 2006. Available at: http://www.cmsa.org/portals/0/pdf/CMAG2.pdf. Accessed May 16, 2012.
21. Neuendorf KA. The Content Analysis Guidebook. Thousand Oaks, CA: Sage Publications, Inc.; 2002.
22. Ingelgård A, Hollowell J, Reddy P, Gold K, Tran K, Fitzmaurice D. What are the barriers to warfarin use in atrial fibrillation? Development of a questionnaire. J Thromb Thrombolysis. 2006;21(3):257-65.
23. Arnsten JH, Gelfand JM, Singer DE. Determinants of compliance with anticoagulation: a case-control study. Am J Med. 1997;103(1):11-17.
24. Smith MB, Christensen N, Wang S, et al. Warfarin knowledge in patients with atrial fibrillation: implications for safety, efficacy, and education strategies. Cardiology. 2010;116(1):61-69.
25. Zeolla MM, Brodeur MR, Dominelli A, Haines ST, Allie ND. Development and validation of an instrument to determine patient knowledge: the oral anticoagulation knowledge test. Ann Pharmacother. 2006;40(4):633-38.
26. Platt AB, Localio AR, Brensinger CM, et al. Risk factors for nonadherence to warfarin: results from the IN-RANGE study. Pharmacoepidemiol Drug Saf. 2008;17(9):853-60. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919157/?tool=pubmed. Accessed May 16, 2012.
27. Cruess DG, Localio AR, Platt AB, et al. Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinics. Int J Behav Med. 2010;17(1):33-42.
28. Rieckmann N, Gerin W, Kronish IM, et al. Course of depressive symptoms and medication adherence after acute coronary syndromes: an electronic medication monitoring study. J Am Coll Cardiol. 2006;48(11):2218-22. Available at: http://content.onlinejacc.org/cgi/reprint/48/11/2218.pdf. Accessed May 16, 2012.
29. Frost MH, Reeve BB, Liepa AM, Stauffer JW, Hays RD; Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group. What is sufficient evidence for the reliability and validity of patient-reported outcome measures? Value Health. 2007;10(Suppl 2):S94-S105.
30. Fisher JD, Fisher WA. The information-motivation behavioral skills model. In: DiClemente RJ, Crosby RA, Kegler MC, eds. Emerging Theories in Health Promotion Practice and Research: Strategies for Improving Public Health. Indianapolis, IN: Jossey-Bass, Inc; 2002.
31. Volpp KG, Loewenstein G, Troxel AB, et al. A test of financial incentives to improve warfarin adherence. BMC Health Serv Res. 2008;8:272. Available at: http://www.biomedcentral.com/1472-6963/8/272. Accessed May 16, 2012.
32. Prins MH, Marrel A, Carita P, et al. Multinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: the 'Perception of Anticoagulant Treatment Questionnaire' (PACT-Q). Health Qual Life Outcomes. 2009;7:9. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654430/?tool=pubmed. Accessed May 16, 2012.
33. Baker JW, Pierce KL, Ryals CA. INR goal attainment and oral anticoagulation knowledge of patients enrolled in an anticoagulation clinic in a Veterans Affairs medical center. J Manag Care Pharm. 2011;17(2):133-42. Available at: http://www.amcp.org/data/jmcp/133-142.pdf.